drugset / Trial / NCT07285070

Tacrolimus Ophthalmic Solution for the Treatment of Non-infectious Anterior Uveitis

NCT07285070 ↗

Phase 2 Recruiting 20 enrolled Novaliq GmbH
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The primary objective of the study is to investigate the safety and tolerability of NOV05 eye drops at two concentrations QID in patients with active non-infectious anterior uveitis.

Timeline

Start
2026-03-16
Primary completion
2026-10
Completion
2026-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Tacrolimus Small molecule — Other